Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability-Reference-Cited by-全球学者库

登录注册会员服务联系我们

Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability

Published:2022-10-03 Issue:10 Volume:21 Page:1259-1268
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Oddone Francesco¹

Affiliation:

1. Glaucoma Unit, IRCSS-Fondazione Bietti, Roma, Italy

Funder

Santen SA, Switzerland

The Italian Ministry of Health and Fondazione Roma

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2135701

Reference62 articles.

1. Santen UK. Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container Summary of product characteristics . 2021. [cited 2021 Feb 15]. Available from: https://medicines.org.uk/emc/product/6917

2. European Glaucoma Society. Terminology and guidelines for glaucoma. 2020 cited 2022 Aug 15]. Available from 2022 Aug 15: https://eugs.org/eng/egs_guidelines_reg.asp?l=1.

3. International Council of Ophthalmology. Guidelines for glaucoma care. 2016 cited 2022 Aug 15]. Available from 2022 Aug 15: https://icoph.org/eye-care-delivery/glaucoma/.

4. Ocular Symptoms and Signs with Preserved and Preservative-Free Glaucoma Medications

5. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP